NCT07214896
Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings
Enrolling by Invitation
PHASE2All AgesInterventionalHealth servicesTruway Health, Inc.
~400 participants
Updated 2025-10-20 on ClinicalTrials.gov
What's tested:Skin Cell DipStem Cell DipWage Token DistributionESG Compliance Monitoring, Operational protocol
At a glance
Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biometric Audit Score ≥85 Across Five Performance Dimensions
Measured over Measured at Day 30 Post-Deployment
Conditions
Where it's being run
4 sites across 4 statesNew York1
Texas1
Germany1
Japan1
Study leadership
- Gavin C Solomon, President & CEO · PRINCIPAL_INVESTIGATOR · Truway Health, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Biometric Audit Score ≥85 Across Five Performance DimensionsMeasured at Day 30 Post-Deployment
This outcome assesses the performance of humanoid robotics units deployed in coalition-aligned healthcare settings. Each unit is scored across five biometric dimensions: motor function, cognitive response, ESG compliance, biotech integration, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Units achieving a composite score ≥85 are eligible for wage token bonuses, dip protocol expansion, and DAO-backed facility scaling.